|
Schrödinger, Inc. (SDGR) DCF Valuation
US | Healthcare | Medical - Healthcare Information Services | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
Schrödinger, Inc. (SDGR) Bundle
Evaluate Schrödinger, Inc.'s (SDGR) financial outlook like an expert! This (SDGR) DCF Calculator provides you with pre-filled financial data and the flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your predictions.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 85.5 | 108.1 | 137.9 | 181.0 | 216.7 | 273.5 | 345.2 | 435.7 | 550.0 | 694.2 |
| Revenue Growth, % | 0 | 26.36 | 27.6 | 31.19 | 19.73 | 26.22 | 26.22 | 26.22 | 26.22 | 26.22 |
| EBITDA | -35.1 | -57.3 | -108.6 | -142.5 | -171.9 | -180.9 | -228.4 | -288.3 | -363.8 | -459.2 |
| EBITDA, % | -41 | -52.97 | -78.73 | -78.73 | -79.34 | -66.16 | -66.16 | -66.16 | -66.16 | -66.16 |
| Depreciation | 3.6 | 3.7 | 2.8 | 4.3 | 5.6 | 8.0 | 10.1 | 12.8 | 16.1 | 20.4 |
| Depreciation, % | 4.26 | 3.38 | 2.06 | 2.4 | 2.56 | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 |
| EBIT | -38.7 | -60.9 | -111.4 | -146.8 | -177.4 | -188.9 | -238.5 | -301.0 | -380.0 | -479.6 |
| EBIT, % | -45.26 | -56.35 | -80.8 | -81.13 | -81.9 | -69.09 | -69.09 | -69.09 | -69.09 | -69.09 |
| Total Cash | 85.8 | 642.7 | 576.5 | 451.1 | 463.0 | 273.5 | 345.2 | 435.7 | 550.0 | 694.2 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 25.7 | 35.4 | 40.6 | 69.1 | 89.1 | 93.8 | 118.4 | 149.5 | 188.7 | 238.1 |
| Account Receivables, % | 30.09 | 32.73 | 29.4 | 38.18 | 41.13 | 34.31 | 34.31 | 34.31 | 34.31 | 34.31 |
| Inventories | .0 | -4.0 | -8.8 | -13.1 | .0 | -9.5 | -11.9 | -15.1 | -19.0 | -24.0 |
| Inventories, % | 0.000001169003 | -3.66 | -6.39 | -7.26 | 0 | -3.46 | -3.46 | -3.46 | -3.46 | -3.46 |
| Accounts Payable | 3.5 | 8.4 | 8.1 | 9.5 | 16.8 | 16.8 | 21.2 | 26.8 | 33.8 | 42.7 |
| Accounts Payable, % | 4.12 | 7.77 | 5.86 | 5.23 | 7.76 | 6.15 | 6.15 | 6.15 | 6.15 | 6.15 |
| Capital Expenditure | -1.8 | -2.5 | -7.2 | -8.0 | -13.4 | -11.1 | -14.0 | -17.7 | -22.3 | -28.2 |
| Capital Expenditure, % | -2.15 | -2.35 | -5.2 | -4.43 | -6.19 | -4.06 | -4.06 | -4.06 | -4.06 | -4.06 |
| Tax Rate, % | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 | 5.12 |
| EBITAT | -38.3 | -61.7 | -111.9 | -146.9 | -168.4 | -186.6 | -235.5 | -297.3 | -375.2 | -473.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -58.7 | -61.4 | -116.9 | -173.4 | -202.0 | -184.9 | -257.1 | -324.5 | -409.6 | -517.1 |
| WACC, % | 10.97 | 10.97 | 10.97 | 10.97 | 10.95 | 10.97 | 10.97 | 10.97 | 10.97 | 10.97 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,190.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -527 | |||||||||
| Terminal Value | -5,881 | |||||||||
| Present Terminal Value | -3,495 | |||||||||
| Enterprise Value | -4,686 | |||||||||
| Net Debt | -27 | |||||||||
| Equity Value | -4,658 | |||||||||
| Diluted Shares Outstanding, MM | 75 | |||||||||
| Equity Value Per Share | -62.12 |
What You Will Get
- Editable Forecast Inputs: Easily modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: Schrödinger, Inc.'s (SDGR) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model designed to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and enhancing efficiency.
Key Features
- Customizable Research Parameters: Adjust essential metrics such as drug discovery timelines, project costs, and success rates.
- Instant Computational Modeling: Provides rapid simulations and predictive analytics for drug development processes.
- High-Precision Results: Leverages Schrödinger’s advanced algorithms for accurate and reliable outcomes.
- Effortless Scenario Testing: Evaluate various drug development strategies and assess their potential impacts with ease.
- Efficiency Booster: Streamlines the research workflow, reducing the need for extensive manual calculations.
How It Works
- Download the Template: Gain immediate access to the Excel-based SDGR DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, profit margins, and other key metrics.
- Instant Calculations: The model automatically recalculates Schrödinger’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial decisions.
Why Choose This Calculator for Schrödinger, Inc. (SDGR)?
- Accurate Data: Utilize real Schrödinger financials for dependable valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Time-Saving: Pre-configured calculations streamline your analysis process.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Easy-to-navigate design and clear instructions cater to users of all experience levels.
Who Should Use This Product?
- Pharmaceutical Researchers: Develop and refine drug discovery models using advanced computational methods.
- Biotech Companies: Leverage predictive modeling to enhance research and development strategies.
- Investors and Analysts: Gain insights into the valuation of Schrödinger, Inc. (SDGR) for informed investment decisions.
- Students and Educators: Utilize cutting-edge technology to learn and teach molecular modeling techniques.
- Industry Professionals: Stay updated on how computational platforms are transforming the life sciences sector.
What the Template Contains
- Pre-Filled Data: Includes Schrödinger, Inc.'s (SDGR) historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Schrödinger, Inc.'s (SDGR) profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.